Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 12

Results: 15

Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1757, doi. 10.1007/s00262-008-0502-9

By:

Benatar, Tania;
Cao, Ming Y.;
Yoon Lee;
Hui Li;
Ningping Feng;
Xiaoping Gu;
Lee, Vivian;
Hongnan Jin;
Ming Wang;
Der, Sandy;
Lightfoot, Jeff;
Wright, Jim A.;
Young, Aiping H.

Publication type:

Article

RhoC a new target for therapeutic vaccination against metastatic cancer.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1871, doi. 10.1007/s00262-008-0517-2

By:

Wenandy, Lynn;
Sørensen, Rikke Bæk;
Svane, Inge Marie;
Straten, Per thor;
Andersen, Mads Hald

Publication type:

Article

Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8+ T cells-mediated protection against melanoma B16 challenge.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1771, doi. 10.1007/s00262-008-0503-8

By:

Mazorra, Zaima;
Mesa, Circe;
Fernández, Audry;
Fernández, Luis E.

Publication type:

Article

HLA typing demands for peptide-based anti-cancer vaccine.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1903, doi. 10.1007/s00262-008-0493-6

By:

Nagorsen, Dirk;
Thiel, Eckhard

Publication type:

Article

Targeting activity of a TCR/IL-2 fusion protein against established tumors.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1781, doi. 10.1007/s00262-008-0504-7

By:

Jinghai Wen;
Xiaoyun Zhu;
Bai Liu;
Lijing You;
Lin Kong;
Hyung-il Lee;
Kai-ping Han;
Wong, Jeffrey L.;
Rhode, Peter R.;
Wong, Hing C.

Publication type:

Article

Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1745, doi. 10.1007/s00262-008-0500-y

By:

Driessens, Gregory;
Gordower, Laurence;
Nuttin, Lise;
Stordeur, Patrick;
Blocklet, Didier;
Egrise, Dominique;
Velu, Thierry;
Bruyns, Catherine

Publication type:

Article

Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivo.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1807, doi. 10.1007/s00262-008-0508-3

By:

Andaloussi, Abdeljabar E.;
Han, Yu;
Lesniak, Maciej S.

Publication type:

Article

Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1849, doi. 10.1007/s00262-008-0512-7

By:

Zhu, Dan;
Corral, Laura G.;
Fleming, Yuedi W.;
Stein, Bernd

Publication type:

Article

Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/ neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1817, doi. 10.1007/s00262-008-0509-2

By:

Amin, Asna;
Benavides, Linda C.;
Holmes, Jarrod P.;
Gates, Jeremy D.;
Carmichael, Mark G.;
Hueman, Matthew T.;
Mittendorf, Elizabeth A.;
Storrer, Catherine E.;
Jama, Yusuf H.;
Craig, Dianna;
Stojadinovic, Alex;
Ponniah, Sathibalan;
Peoples, George E.

Publication type:

Article

Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1837, doi. 10.1007/s00262-008-0511-8

By:

Westerterp, Marinke;
Boermeester, Marja A.;
Omloo, Jikke M.T.;
Hulshof, Maarten C.C.M.;
Vervenne, Walter L.;
Lutter, Rene;
Out, Theo A.;
van Lanschot, J. Jan B

Publication type:

Article

Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1879, doi. 10.1007/s00262-008-0518-1

By:

Schmidt, Michael M.;
Thurber, Greg M.;
Wittrup, K. Dane

Publication type:

Article

Selective accumulation of differentiated FOXP3+ CD4+ T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1795, doi. 10.1007/s00262-008-0507-4

By:

Jandus, Camilla;
Bioley, Gilles;
Speiser, Daniel E.;
Romero, Pedro

Publication type:

Article

Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1861, doi. 10.1007/s00262-008-0514-5

By:

Yamaguchi, Shinjiro;
Tatsumi, Tomohide;
Takehara, Tetsuo;
Sasakawa, Akira;
Hikita, Hayato;
Kohga, Keisuke;
Uemura, Akio;
Sakamori, Ryotaro;
Ohkawa, Kazuyoshi;
Hayashi, Norio

Publication type:

Article

Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1827, doi. 10.1007/s00262-008-0510-9

By:

Ciesielski, Michael J.;
Kozbor, Danuta;
Castanaro, Carla A.;
Barone, Tara A.;
Fenstermaker, Robert A.

Publication type:

Article

Intratumoral immunocytokine treatment results in enhanced antitumor effects.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1891, doi. 10.1007/s00262-008-0519-0

By:

Johnson, Erik E.;
Lum, Hillary D.;
Rakhmilevich, Alexander L.;
Schmidt, Brian E.;
Furlong, Meghan;
Buhtoiarov, Ilia N.;
Hank, Jacquelyn A.;
Raubitschek, Andrew;
Colcher, David;
Reisfeld, Ralph A.;
Gillies, Stephen D.;
Sondel, Paul M.

Publication type:

Article

Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 12

Virulizin<sup>®</sup> induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors.

RhoC a new target for therapeutic vaccination against metastatic cancer.

Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8<sup>+</sup> T cells-mediated protection against melanoma B16 challenge.

HLA typing demands for peptide-based anti-cancer vaccine.

Targeting activity of a TCR/IL-2 fusion protein against established tumors.

Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.

Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivo.

Immunomodulatory drugs Revlimid<sup>®</sup> (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation.

Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/ neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus.

Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability.

Selective accumulation of differentiated FOXP3<sup>+</sup> CD4<sup>+</sup> T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood.

Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity.

Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma.

Intratumoral immunocytokine treatment results in enhanced antitumor effects.